9m
ViroGates A/S: ViroGates submits its De Novo application to the U.S. FDA for suPARnostic TurbiLatex
BIRKERØD, DENMARK - ViroGates A/S ("ViroGates"), a medical technology company developing blood tests for measuring chronic inflammation ...
On March 18th, the FDA published draft guidance on validating new approach methodologies (NAMs), including complex in vitro ...
By David Shepardson WASHINGTON, April 8 (Reuters) - The U.S. Federal Aviation Administration on Wednesday proposed a $255,000 ...
In practical terms, most people likely use antimicrobial drugs within a normal range. We commonly see outliers that stretch the intended range due to poor treatment decisions, unapproved use, illegal ...
AbbVie has filed a lawsuit against the U.S. government, seeking clearer guidance on patients eligible for a drug discount ...
A federal judge ruled mifepristone can still be mailed nationwide for now but warned the abortion pill's FDA guidelines could ...
One year into his tumultuous tenure as the FDA’s commissioner, Marty Makary, M.D., has laid out ambitious internal goals and ...
The US Food and Drug Administration (FDA) has announced that starting on 1 October 2026, manufacturers must submit adverse ...
A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S.
The agency’s 2023 decision to place 19 peptides on the “unsafe” list was supported by numerous documented safety concerns, ...
FDA issues guidance compounded GLP-1 production limits, restricting pharmacies to compound only during active shortages to ensure drug safety and ...
HHSC Directs Health Care Facilities to Follow FDA Cybersecurity Guidance The Texas Health and Human Services Commission is directing all health care facilities to review, understand and mitigate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results